Internal Reference Number: FOI_7074
Date Request Received: 16/03/2023 00:00:00
Date Request Replied To: 11/04/2023 00:00:00
This response was sent via: By Email
Request Summary: Treatment of Colorectal Cancer
Request Category: Companies
| Question Number 1: How many colorectal cancer [CRC] patients have been treated in the past 3 months with the following agents: • Aflibercept • Bevacizumab • Capecitabine • CAPIRI • CAPOX (XELOX) • Cetuximab in combination with FOLFIRI • Cetuximab in combination with FOLFOX • Cetuximab not in combination with FOLFIRI or FOLFOX • Irinotecan only • FOLFIRI • FOLFOX • Fluorouracil (5FU) only • Oxaliplatin only • Panitumumab in combination with FOLFIRI • Panitumumab in combination with FOLFOX • Panitumumab not in combination with FOLFIRI or FOLFOX • Pembrolizumab • Nivolumab • Raltitrexed • Ramucirumab • Regorafenib • Sorafenib • Other active systemic anti-cancer therapy • Palliative care only | |
| Answer To Question 1: How many colorectal cancer [CRC] patients have been treated in the past 3 months with the following agents: • Aflibercept 0 • Bevacizumab 0 • Capecitabine <5 • CAPIRI 0 • CAPOX (XELOX) 22 • Cetuximab in combination with FOLFIRI 0 • Cetuximab in combination with FOLFOX 0 • Cetuximab not in combination with FOLFIRI or FOLFOX 0 • Irinotecan only 0 • FOLFIRI <5 • FOLFOX 6 • Fluorouracil (5FU) only 0 • Oxaliplatin only 0 • Panitumumab in combination with FOLFIRI <5 • Panitumumab in combination with FOLFOX <5 • Panitumumab not in combination with FOLFIRI or FOLFOX 0 • Pembrolizumab <5 • Nivolumab 0 • Raltitrexed 0 • Ramucirumab 0 • Regorafenib 0 • Sorafenib 0 • Other active systemic anti-cancer therapy <5 • Palliative care only unable to answer | |
| To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
